| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 483.73 KB | Adobe PDF |
Orientador(es)
Resumo(s)
We report the case of a patient with symptoms of myelopathy following acute SARS-CoV-2 infection. MRI documented a longitudinally extensive transverse myelitis and further investigation was unremarkable with the exception of positivity for MOG-IgG in serum. This report extends the spectrum of post-COVID-19 neurological syndromes, and documents a very significant improvement to long-term oral corticosteroid therapy in this setting. Further prospective studies are needed to establish the risk of recurrence in this subset of patients.
Descrição
© 2021 Elsevier B.V. All rights reserved.
Palavras-chave
COVID-19 MOG-IgG Myelitis Post-infectious myelitis SARS-CoV-2
Contexto Educativo
Citação
J Neuroimmunol. 2021 Dec 15;361:577739
Editora
Elsevier
